Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Familial adenomatous polyposis Indication Strategy Report 2026: APC, Trials and Deals
3 August 2026
2026 Familial adenomatous polyposis indication strategy covering epidemiology, APC biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
MUTYH-associated polyposis Indication Strategy Report 2026: MUTYH, Trials and Deals
3 August 2026
2026 MUTYH-associated polyposis indication strategy covering epidemiology, MUTYH biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Juvenile polyposis syndrome Indication Strategy Report 2026: SMAD4, Trials and Deals
3 August 2026
2026 Juvenile polyposis syndrome indication strategy covering epidemiology, SMAD4 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Cowden syndrome Indication Strategy Report 2026: PTEN, Trials and Deals
3 August 2026
2026 Cowden syndrome indication strategy covering epidemiology, PTEN biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Peutz-Jeghers syndrome Indication Strategy Report 2026: STK11, Trials and Deals
3 August 2026
2026 Peutz-Jeghers syndrome indication strategy covering epidemiology, STK11 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Blue rubber bleb nevus syndrome Indication Strategy Report 2026: TEK, Trials and Deals
3 August 2026
2026 Blue rubber bleb nevus syndrome indication strategy covering epidemiology, TEK biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Intestinal Behcet disease Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Intestinal Behcet disease indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Radiation proctitis Indication Strategy Report 2026: TGF-beta, Trials and Deals
3 August 2026
2026 Radiation proctitis indication strategy covering epidemiology, TGF-beta biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Diversion colitis Indication Strategy Report 2026: PPAR-gamma, Trials and Deals
3 August 2026
2026 Diversion colitis indication strategy covering epidemiology, PPAR-gamma biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Chronic antibiotic-refractory pouchitis Indication Strategy Report 2026: IL-23, Trials and Deals
3 August 2026
2026 Chronic antibiotic-refractory pouchitis indication strategy covering epidemiology, IL-23 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Pancreaticopleural fistula Indication Strategy Report 2026: Somatostatin receptor, Trials and Deals
3 August 2026
2026 Pancreaticopleural fistula indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition…
Latest Hotspot
8 min read
Pancreatic ascites Indication Strategy Report 2026: Somatostatin receptor, Trials and Deals
3 August 2026
2026 Pancreatic ascites indication strategy covering epidemiology, Somatostatin receptor biology, active trials, transactions, unmet need, competition and market…